# Nivolumab Monotherapy and Nivolumab Plus Ipilimumab in Recurrent Small Cell Lung Cancer: Results From the CheckMate 032 Randomized Cohort

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/nivolumab-monotherapy-and-nivolumab-plus-ipilimumab-in-recurrent-small-cell-lung/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Neal Ready,Patrick A. Ott,Matthew D. Hellmann,Jon Zugazagoitia,Christine L. Hann,Filippo de Braud,Scott Antonia,Paolo A. Ascierto,Víctor Moreno,Akin Atmaca,Stefania Salvagni,Matthew H. Taylor,Asim Amin,D. Ross Camidge,Leora Horn,Emiliano Calvo,Ang Li,Wen Lin,Margaret K. Callahan,David R. Spigel |
| Citations | 328 |
| DOI | 10.1016/j.jtho.2019.10.004 |
| Fields | Medicine |
| Open Access | true |
| OA Status | hybrid |
| OA URL | http://www.jto.org/article/S1556086419335312/pdf |
| OpenAlex ID | https://openalex.org/W2980593108 |
| PMID | 31629915 |
| Type | article |
| Year | 2019 |

## Paper authors

- [Ang Li](https://scholariq.org/researchers/ang-li/)
- [Matthew D. Hellmann](https://scholariq.org/researchers/matthew-d-hellmann/)
- [David R. Spigel](https://scholariq.org/researchers/david-r-spigel/)

## Paper journal

- [Journal of Thoracic Oncology](https://scholariq.org/journals/journal-of-thoracic-oncology/)

## Paper primary topic

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)

## Paper topics

- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Neuroendocrine Tumor Research Advances](https://scholariq.org/topics/neuroendocrine-tumor-research-advances/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.